Tyers Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Tyers Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$545K	Sell	5,566 -374	-6%	-$42.2K	0.02%	450
2019 Q2	$778K	Sell	5,940 -2,024	-25%	-$261K	0.03%	379
2019 Q1	$1.08M	Buy	7,964 +1,958	+33%	+$243K	0.04%	301
2018 Q4	$585K	Sell	6,006 -110	-2%	-$13K	0.02%	374
2018 Q3	$850K	Buy	6,116 +66	+1%	+$8.28K	0.03%	330
2018 Q2	$751K	Buy	6,050 +814	+16%	+$95.1K	0.03%	345
2018 Q1	$584K	Sell	5,236 -220	-4%	-$26.3K	0.02%	380
2017 Q4	$653K	Buy	5,456 +1,518	+39%	+$185K	0.02%	368
2017 Q3	$552K	Sell	3,938 -704	-15%	-$95.6K	0.02%	379
2017 Q2	$565K	Buy	4,642 +374	+9%	+$43.5K	0.02%	377
2017 Q1	$517K	Buy	4,268 +660	+18%	+$85.1K	0.02%	384
2016 Q4	$441K	Buy	+3,608	New	+$441K	0.02%	374

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tyers Asset Management's ALXN Position: Q3 2019 in Review

Tyers Asset Management reduced its Alexion Pharmaceuticals (ALXN) stake by 6.3% in Q3 2019, selling an estimated $42.2K and leaving 5,566 shares worth $545K. The position accounts for 0.02% of the portfolio, ranked #450.

Tyers Asset Management first reported a position in ALXN in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.08M in Q1 2019. 646 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

Tyers Asset Management held 5,566 shares of Alexion Pharmaceuticals worth $545K as of Q3 2019.
Tyers Asset Management sold 374 Alexion Pharmaceuticals shares in Q3 2019, an estimated $42.2K.
Alexion Pharmaceuticals made up 0.02% of Tyers Asset Management's portfolio in Q3 2019, its #450 holding.
Tyers Asset Management first reported a position in Alexion Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Alexion Pharmaceuticals position peaked at $1.08M in Q1 2019.
646 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.